Continuing fluoxetine treatment may delay relapse in children and adolescents with major depressive disorderFluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.

  • Wilkinson, Dr Paul MB BChir, MRCPsych (commentator)
  • Emslie, GJ
  • Heiligenstein, JH
  • Hoog, SL
  • et al,

  • Research Psychiatrist, Section of Developmental Psychiatry, University of Cambridge, Cambridge, UK.

Emslie GJ, Heiligenstein JH, Hoog SL, et al. Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 2004; 43: 1397–405.EmslieGJHeiligensteinJHHoogSLet alFluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study.J Am Acad Child Adolesc Psychiatry2004431397-405Q Does fluoxetine prevent relapse of major depressive disorder in children and adolescents?

For correspondence: Dr John H Heiligenstein, c/o Dr Jacobson, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA

Sources of funding: Eli Lilly and Company.

Evidence-Based Mental Health 8(2):p 37, May 2005.
Copyright © 2005 by BMJ Publishing Group Ltd, Royal College of Psychiatrists, & British Psychological Society